There are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the United States with respect to hospitalization, admission to an intensive care unit (ICU), or ambulatory care in an emergency department or urgent care clinic.

Matéria original

A edição n° 66 da Revista Facto chegou. Acesse agora!
Anterior

A edição n° 66 da Revista Facto chegou. Acesse agora!

Próxima

EFFECT OF TOCILIZUMAB IN MORTALITY AMONG PATIENTS WITH SEVERE AND CRITICAL COVID-19: EXPERIENCE IN A THIRD-LEVEL MEDICAL CENTER